Gene: SMYD5
Official Full Name: SMYD family member 5provided by HGNC
Gene Summary: Enables protein-lysine N-methyltransferase activity. Involved in positive regulation of cytoplasmic translational elongation; regulation of stem cell differentiation; and transposable element silencing by heterochromatin formation. Is active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01663 | SMYD5 Knockout cell line (HeLa) | Human | SMYD5 | 1:3~1:6 | Negative | Online Inquiry |
KO01664 | SMYD5 Knockout cell line (HCT 116) | Human | SMYD5 | 1:2~1:4 | Negative | Online Inquiry |
KO01665 | SMYD5 Knockout cell line (HEK293) | Human | SMYD5 | 1:3~1:6 | Negative | Online Inquiry |
KO01666 | SMYD5 Knockout cell line (A549) | Human | SMYD5 | 1:3~1:4 | Negative | Online Inquiry |
SMYD5 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the functional roles of the SMYD5 gene, a member of the SET and MYND domain-containing protein family known to influence various biological processes, including gene expression regulation and cellular signaling pathways. By creating a knockout of the SMYD5 gene, these cell lines enable researchers to dissect the mechanistic pathways influenced by this gene, facilitating insights into its contributions to oncogenesis and other diseases.
The primary function of SMYD5 Gene Knockout Cell Lines lies in their ability to simulate the absence of SMYD5 protein expression, thereby providing a platform for investigating the downstream effects on signaling networks and phenotypic changes in cellular behavior. This is typically achieved through CRISPR-Cas9 gene-editing technology, which allows for precise and efficient disruption of the target gene, ensuring that researchers can analyze cellular responses under controlled conditions.
In the context of scientific research and clinical applications, SMYD5 Gene Knockout Cell Lines are invaluable tools for drug discovery, target validation, and understanding disease mechanisms, particularly in cancer biology. By elucidating the pathways perturbed by the loss of SMYD5, these cellular models can aid in the identification of novel therapeutic targets, ultimately advancing translational research.
One key advantage of our SMYD5 Gene Knockout Cell Lines is their high efficiency and reliability, confirmed through rigorous validation. Unlike traditional models that may not adequately represent the complexities of gene knockout, our cell lines have undergone stringent quality control processes, ensuring reproducible and consistent results. Additionally, these lines are available for a range of cell types, allowing for versatility across various research applications.
Researchers, clinicians, and biopharmaceutical companies will find great value in SMYD5 Gene Knockout Cell Lines as they navigate the complexities of gene function and interaction, ultimately fostering advances in precision medicine and targeted therapies. With a commitment to quality and innovation in biological research tools, our company remains at the forefront of providing high-quality genetic models that empower scientific inquiry and contribute to medical breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.